Neuronetics Files Proxy Materials
Ticker: STIM · Form: DEFA14A · Filed: Oct 9, 2024 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | DEFA14A |
| Filed Date | Oct 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $15,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance
TL;DR
NEURONETICS filed more proxy docs, looks like standard shareholder stuff.
AI Summary
Neuronetics, Inc. filed a Definitive Additional Materials proxy statement on October 9, 2024. This filing relates to the company's proxy materials, which were previously filed on October 4, 2024. The company is incorporated in Delaware and its fiscal year ends on December 31st. Its principal business address is in Malvern, PA.
Why It Matters
This filing indicates that Neuronetics is proceeding with its shareholder communication and governance processes, which are essential for the company's ongoing operations and strategic decisions.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement, indicating standard corporate governance procedures rather than a significant event.
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- 3222 PHOENIXVILLE PIKE (address) — Business and Mail Address
- MALVERN (city) — Business and Mail City
- PA (state) — Business and Mail State
- 19355 (zip_code) — Business and Mail Zip Code
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically marked as Definitive Additional Materials.
When was the initial proxy statement filed?
The initial proxy statement was filed on October 4, 2024.
What is the company's name?
The company's name is Neuronetics, Inc.
Where is Neuronetics, Inc. located?
Neuronetics, Inc.'s business and mail address is 3222 Phoenixville Pike, Malvern, PA 19355.
What is the SIC code for Neuronetics, Inc.?
The Standard Industrial Classification (SIC) code for Neuronetics, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 345 words · 1 min read · ~1 pages · Grade level 8.7 · Accepted 2024-10-09 16:30:26
Key Financial Figures
- $15,000 — ing will be paid a fee of approximately $15,000.00, plus additional fees for additional
Filing Documents
- d885524ddefa14a.htm (DEFA14A) — 10KB
- 0001193125-24-235238.txt ( ) — 11KB
From the Filing
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a-12 NEURONETICS, INC. (Name of Registrant as Specified in its Charter) N/A (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 EXPLANATORY NOTE On October 4, 2024, Neuronetics, Inc. (the Neuronetics ) filed with the Securities and Exchange Commission its Definitive Proxy disclose that Neuronetics engaged a proxy solicitor after filing the Proxy Statement. This supplement should be read together with the Proxy Statement, which should be read in its entirety. PROXY SOLICITOR Neuronetics has engaged D.F. King & Co., Inc. ( D.F. King ) to assist in the proxy solicitation process. D.F. King will be paid a fee of approximately $15,000.00, plus additional fees for additional services at D.F. Kings reasonable and customary rates, plus reimbursements for costs and expenses incurred by D.F. King. D.F. King is authorized to contact the stockholders of Neuronetics to ensure awareness of the Special Meeting and the matters to be considered at the Special Meeting. If you have any questions concerning the Special Meeting or the Proxy Statement, would like additional copies of the Proxy Statement or need help voting your shares of the Neuronetics Common Stock, please contact D.F. King. D.F. King & Co., Inc. Banks and Brokers Call Collect: (212) 269-5550 All Others Call Toll-Free: (866) 864-4943 Email: STIM@dfking.com